what is a glp 1 antagonist Comparing Ozempic, Wegovy and Other GLP-1 Drugs Exploring the Side Effects of
Description
Still in trials: Orforglipron is not yet FDA-approved
1 Irregular heartbeats were reported in 2 to 11% of people on retatrutide compared with around 2% on placebo, none classified as serious so far
It really is confusing even for a pharmacist, she said
Still, the research cited post-usage boomerangs and found that 50% of previous users are likely to use these drugs again
And only around 10% of people were able to maintain all the weight theyve lost
